Investor FAQs

Where and when was Kezar Life Sciences incorporated?
Kezar Life Sciences was incorporated in Delaware in February, 2015
Who is Kezar’s transfer agent and how do I contact them?
Kezar Life Sciences transfer agent is Computershare Trust Company, N.A.. Please see below for the transfer agent contact information:

Computershare Trust Company, N.A.
P.O Box 505000
Louisville, KY 40233-5000

Phone (US): (877) 373-6374
Phone (non-US): (781) 575-2879
Where is Kezar Life Sciences headquartered?
4000 Shoreline Court, Suite 300, South San Francisco, CA 94080
When did Kezar Life Sciences go public?
Kezar’s shares of common stock first started trading on The Nasdaq Global Select Market on June 21, 2018.
On which exchange is Kezar Life Sciences listed and what is the ticker symbol?
Kezar's common stock is traded on The Nasdaq Global Select Market under the symbol “KZR”.
How can I purchase shares?
Shares can be purchased through any registered broker. Kezar does not have a direct stock purchase plan.
Does Kezar Life Sciences pay dividends and have a dividend reinvestment program?
Currently, Kezar Life Sciences does not pay dividends or offer a dividend reinvestment program.
What is Kezar’s CUSIP number?
49372L 100.
What is Kezar’s fiscal year-end?
Kezar’s fiscal year-end is December 31st
Who are Kezar’s independent auditors?
KPMG LLP.
Where can I find recent Kezar press releases?
You can view our recent press releases by visiting the “Press Releases” section of our website.
How can I sign up to receive Kezar’s press releases and other company information?
Please visit the “Investor Resources” section of our website and choose the "Email Alerts" button to be added to the Kezar distribution list.
How can I view documents Kezar Life Sciences has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Quarterly and annual reports, as well as other SEC filings, can be accessed in the Financial Information section of our “Investors & Media” website page or directly from the SEC at www.sec.gov.
If I have questions regarding Kezar Life Sciences that have not been answered, whom should I contact?
Investor relations inquiries may be submitted to Alex Gray at Burns McClellan at +1-212-213-0006 or agray@burnsmc.com.